Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ZW-171 by Zymeworks for Non-Small Cell Lung Cancer: Likelihood of Approval
ZW-171 is under clinical development by Zymeworks and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
ZW-171 by Zymeworks for Ovarian Cancer: Likelihood of Approval
ZW-171 is under clinical development by Zymeworks and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I...
ZW-171 by Zymeworks for Malignant Mesothelioma: Likelihood of Approval
ZW-171 is under clinical development by Zymeworks and currently in Phase I for Malignant Mesothelioma. According to GlobalData, Phase I...
ZW-171 by Zymeworks for Solid Tumor: Likelihood of Approval
ZW-171 is under clinical development by Zymeworks and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
ZW-171 by Zymeworks for Colorectal Cancer: Likelihood of Approval
ZW-171 is under clinical development by Zymeworks and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...